Model and Clinicopathologic Variables 2x2 Performance Metrics | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Training Cohort | Validation Cohort | ||||||||
Variable | Rec. Status at 10 Years | Metrics | Rec. Status at 10 Years | Metrics | ||||||
Model | Â | Censored | Recurred | Acc: 0.87 | PPV: 0.65 | Â | Censored | Recurred | Acc: 0.85 | PPV: 0.46 |
Low Risk | 116 | 9 | Sn: 0.71 | NPV: 0.93 | Low Risk | 144 | 13 | Sn: 0.50 | NPV: 0.92 | |
High Risk | 12 | 22 | Sp: 0.91 | OR: 23.6 | High Risk | 15 | 13 | Sp: 0.91 | OR: 9.60 | |
Necrosis | Â | Censored | Recurred | Acc: 0.41 | PPV: 0.18 | Â | Censored | Recurred | Acc: 0.26 | PPV: 0.13 |
No | 47 | 13 | Sn: 0.58 | NPV: 0.78 | No | 28 | 6 | Sn: 0.77 | NPV: 0.82 | |
Yes | 81 | 18 | Sp: 0.37 | OR: 0.80 | Yes | 131 | 20 | Sp: 0.18 | OR: 0.71 | |
Size | Â | Censored | Recurred | Acc: 0.50 | PPV: 0.15 | Â | Censored | Recurred | Acc: 0.49 | PPV: 0.10 |
Below | 68 | 20 | Sn: 0.33 | NPV: 0.77 | Below | 83 | 18 | Sn: 0.31 | NPV: 0.82 | |
Above | 58 | 10 | Sp: 0.54 | OR: 0.59 | Above | 76 | 8 | Sp: 0.52 | OR: 0.49 | |
Age | Â | Censored | Recurred | Acc: 0.27 | PPV: 0.18 | Â | Censored | Recurred | Acc: 0.24 | PPV: 0.15 |
Below | 19 | 7 | Sn: 0.77 | NPV: 0.73 | Below | 21 | 2 | Sn: 0.92 | NPV: 0.91 | |
Above | 109 | 24 | Sp: 0.15 | OR: 0.60 | Above | 138 | 24 | Sp: 0.13 | OR: 1.83 | |
Radiotherapy | Â | Censored | Recurred | Acc: 0.64 | PPV: 0.19 | Â | Censored | Recurred | Acc: 0.66 | PPV: 0.05 |
No | 94 | 23 | Sn: 0.26 | NPV: 0.80 | No | 121 | 24 | Sn: 0.08 | NPV: 0.83 | |
Yes | 34 | 8 | Sp: 0.73 | OR: 0.96 | Yes | 38 | 2 | Sp: 0.76 | OR: 0.27 | |
Grade | Â | Censored | Recurred | Acc: 0.41 | PPV: 0.21 | * | ||||
I/II | 41 | 8 | Sn: 0.74 | NPV: 0.84 | ||||||
III | 86 | 23 | Sp: 0.32 | OR: 1.37 |